Clinical Trial Detail

NCT ID NCT01546038
Title A Study To Evaluate PF-04449913 With Chemotherapy In Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Pfizer
Indications

acute myeloid leukemia

Therapies

Glasdegib

Cytarabine

Decitabine

Cytarabine + Daunorubicin

Age Groups: adult

No variant requirements are available.